1. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee;Goldsmith;J Rheumatol,1993
2. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials;Boers;J Rheumatol Suppl,1994
3. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials;Felson;Arthritis Rheum,1993
4. The work of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT);Smolen;Br J Rheumatol,1992
5. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate;Mallya;J Rheumatol,1982